vs
Side-by-side financial comparison of RICHARDSON ELECTRONICS, LTD. (RELL) and Xtant Medical Holdings, Inc. (XTNT). Click either name above to swap in a different company.
RICHARDSON ELECTRONICS, LTD. is the larger business by last-quarter revenue ($52.3M vs $32.4M, roughly 1.6× Xtant Medical Holdings, Inc.). Xtant Medical Holdings, Inc. runs the higher net margin — 0.2% vs -0.2%, a 0.4% gap on every dollar of revenue. On growth, RICHARDSON ELECTRONICS, LTD. posted the faster year-over-year revenue change (5.7% vs 2.7%). Xtant Medical Holdings, Inc. produced more free cash flow last quarter ($5.0M vs $-1.7M). Over the past eight quarters, Xtant Medical Holdings, Inc.'s revenue compounded faster (7.7% CAGR vs -0.3%).
The James Richardson Corporation, also going by the name James Richardson Group or JR/Group, is an Australian furniture, hospitality, real estate and retail corporation, headquartered in the Abbotsford suburb of Melbourne, Australia. It is privately owned and employs approximately 2,300 people worldwide. It is perhaps best known among consumers for its duty-free retail stores in airports and border crossings in Australasia and the Middle East. The company is a household name in Israel due to ...
Xtant Medical Holdings, Inc. is a global medical technology company that develops, manufactures and markets orthobiologic products, neurosurgery devices, and regenerative medicine solutions for orthopedic and neurological care providers. It serves patients and medical institutions across North America, Europe and the Asia-Pacific, with core segments covering spinal surgery supplies and bone regeneration products.
RELL vs XTNT — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $52.3M | $32.4M |
| Net Profit | $-121.0K | $57.0K |
| Gross Margin | 30.7% | 54.9% |
| Operating Margin | 0.3% | -2.9% |
| Net Margin | -0.2% | 0.2% |
| Revenue YoY | 5.7% | 2.7% |
| Net Profit YoY | 83.9% | 101.8% |
| EPS (diluted) | — | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $52.3M | $32.4M | ||
| Q3 25 | $54.6M | $33.3M | ||
| Q2 25 | — | $35.4M | ||
| Q1 25 | $53.8M | $32.9M | ||
| Q4 24 | $49.5M | $31.5M | ||
| Q3 24 | $53.7M | $27.9M | ||
| Q2 24 | — | $29.9M | ||
| Q1 24 | $52.4M | $27.9M |
| Q4 25 | $-121.0K | $57.0K | ||
| Q3 25 | $1.9M | $1.3M | ||
| Q2 25 | — | $3.5M | ||
| Q1 25 | $-2.1M | $58.0K | ||
| Q4 24 | $-751.0K | $-3.2M | ||
| Q3 24 | $590.0K | $-5.0M | ||
| Q2 24 | — | $-3.9M | ||
| Q1 24 | $750.0K | $-4.4M |
| Q4 25 | 30.7% | 54.9% | ||
| Q3 25 | 31.0% | 66.1% | ||
| Q2 25 | — | 68.6% | ||
| Q1 25 | 31.0% | 61.5% | ||
| Q4 24 | 31.0% | 50.9% | ||
| Q3 24 | 30.6% | 58.4% | ||
| Q2 24 | — | 62.1% | ||
| Q1 24 | 29.5% | 62.1% |
| Q4 25 | 0.3% | -2.9% | ||
| Q3 25 | 1.8% | 7.6% | ||
| Q2 25 | — | 13.1% | ||
| Q1 25 | -5.1% | 3.2% | ||
| Q4 24 | -1.3% | -6.0% | ||
| Q3 24 | 0.6% | -13.5% | ||
| Q2 24 | — | -9.8% | ||
| Q1 24 | 1.9% | -12.4% |
| Q4 25 | -0.2% | 0.2% | ||
| Q3 25 | 3.5% | 3.9% | ||
| Q2 25 | — | 10.0% | ||
| Q1 25 | -3.8% | 0.2% | ||
| Q4 24 | -1.5% | -10.0% | ||
| Q3 24 | 1.1% | -18.0% | ||
| Q2 24 | — | -12.9% | ||
| Q1 24 | 1.4% | -15.8% |
| Q4 25 | — | $0.00 | ||
| Q3 25 | — | $0.01 | ||
| Q2 25 | — | $0.02 | ||
| Q1 25 | — | $0.00 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $-0.04 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | — | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $33.1M | $17.1M |
| Total DebtLower is stronger | — | $11.0M |
| Stockholders' EquityBook value | $158.5M | $51.0M |
| Total Assets | $201.8M | $94.1M |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $33.1M | $17.1M | ||
| Q3 25 | $35.7M | $10.4M | ||
| Q2 25 | — | $6.9M | ||
| Q1 25 | $36.7M | $5.0M | ||
| Q4 24 | $26.6M | $6.2M | ||
| Q3 24 | $23.0M | $6.6M | ||
| Q2 24 | — | $5.4M | ||
| Q1 24 | $18.9M | $4.5M |
| Q4 25 | — | $11.0M | ||
| Q3 25 | — | $17.4M | ||
| Q2 25 | — | $22.3M | ||
| Q1 25 | — | $22.2M | ||
| Q4 24 | — | $22.0M | ||
| Q3 24 | — | $19.1M | ||
| Q2 24 | — | $21.8M | ||
| Q1 24 | — | $16.8M |
| Q4 25 | $158.5M | $51.0M | ||
| Q3 25 | $159.4M | $50.4M | ||
| Q2 25 | — | $48.5M | ||
| Q1 25 | $152.9M | $43.9M | ||
| Q4 24 | $156.2M | $43.0M | ||
| Q3 24 | $159.1M | $45.7M | ||
| Q2 24 | — | $45.0M | ||
| Q1 24 | $158.6M | $47.7M |
| Q4 25 | $201.8M | $94.1M | ||
| Q3 25 | $200.1M | $106.3M | ||
| Q2 25 | — | $103.5M | ||
| Q1 25 | $189.8M | $95.8M | ||
| Q4 24 | $195.2M | $93.8M | ||
| Q3 24 | $197.9M | $98.9M | ||
| Q2 24 | — | $95.6M | ||
| Q1 24 | $193.6M | $93.9M |
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 0.46× | ||
| Q1 25 | — | 0.51× | ||
| Q4 24 | — | 0.51× | ||
| Q3 24 | — | 0.42× | ||
| Q2 24 | — | 0.48× | ||
| Q1 24 | — | 0.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-99.0K | $5.4M |
| Free Cash FlowOCF − Capex | $-1.7M | $5.0M |
| FCF MarginFCF / Revenue | -3.3% | 15.4% |
| Capex IntensityCapex / Revenue | 3.1% | 1.2% |
| Cash ConversionOCF / Net Profit | — | 94.39× |
| TTM Free Cash FlowTrailing 4 quarters | $7.6M | $10.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-99.0K | $5.4M | ||
| Q3 25 | $1.4M | $4.6M | ||
| Q2 25 | — | $1.3M | ||
| Q1 25 | $4.6M | $1.3M | ||
| Q4 24 | $5.5M | $665.0K | ||
| Q3 24 | $412.0K | $-1.7M | ||
| Q2 24 | — | $-5.1M | ||
| Q1 24 | $-2.5M | $-5.8M |
| Q4 25 | $-1.7M | $5.0M | ||
| Q3 25 | $342.0K | $4.2M | ||
| Q2 25 | — | $910.0K | ||
| Q1 25 | $4.1M | $87.0K | ||
| Q4 24 | $4.9M | $-7.0K | ||
| Q3 24 | $-514.0K | $-3.8M | ||
| Q2 24 | — | $-5.7M | ||
| Q1 24 | $-2.9M | $-6.5M |
| Q4 25 | -3.3% | 15.4% | ||
| Q3 25 | 0.6% | 12.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | 7.5% | 0.3% | ||
| Q4 24 | 10.0% | -0.0% | ||
| Q3 24 | -1.0% | -13.7% | ||
| Q2 24 | — | -18.9% | ||
| Q1 24 | -5.6% | -23.4% |
| Q4 25 | 3.1% | 1.2% | ||
| Q3 25 | 1.9% | 1.3% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | 1.0% | 3.6% | ||
| Q4 24 | 1.0% | 2.1% | ||
| Q3 24 | 1.7% | 7.5% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | 0.8% | 2.8% |
| Q4 25 | — | 94.39× | ||
| Q3 25 | 0.72× | 3.53× | ||
| Q2 25 | — | 0.36× | ||
| Q1 25 | — | 22.03× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.37× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RELL
| Power And Microwave Technologies Group | $35.2M | 67% |
| Canvys | $8.8M | 17% |
| Global Energy Solutions | $8.3M | 16% |
XTNT
| Orthobiologics | $18.3M | 57% |
| Spinal Implant | $9.4M | 29% |
| License Revenue | $4.6M | 14% |
